imaging-ultrasound (MRI/US) fusion system. Prostate cancer has traditionally been
diagnosed via transrectal ultrasound (TRUS) biopsy. Though considered the gold standard,
TRUS is unable to visualize most prostate cancer lesions and therefore requires sampling of
the entire prostate. This biopsy method often undergrades prostate cancer and fails to detect
up to 35% of cancers on initial biopsy. Prostate MRI has been shown to have excellent …